Close Menu

Good, Not Great

It's no secret that the rate of scientific papers being retracted or corrected post-publication is rising, but researchers and editors aren't all seeing that trend as a cause for concern, reports Nature News' Richard Van Noorden. In the early 2000s, an average of about 30 retraction notices appeared each year, but this year alone, that number is at about 400, Van Noorden says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.